B. A. Ahmed, B. C. Jeffus, S. I. Bukhari, J. T. Harney, R. Unal et al., Serotonin Transamidates Rab4 and Facilitates Its Binding to the C Terminus of Serotonin Transporter, Journal of Biological Chemistry, vol.283, issue.14, pp.9388-9398, 2008.
DOI : 10.1074/jbc.M706367200

D. M. Angeles, J. Williams, L. Zhang, and W. J. Pearce, Acute hypoxia modulates 5-HT receptor density and agonist affinity in fetal and adult ovine carotid arteries, Am J Physiol Heart Circ Physiol, vol.279, pp.502-510, 2000.

D. M. Angeles, J. Williams, R. E. Purdy, L. Zhang, and W. J. Pearce, Effects of maturation and acute hypoxia on receptor-IP(3) coupling in ovine common carotid arteries, Am J Physiol Regul Integr Comp Physiol, vol.280, pp.410-417, 2001.

A. K. Banes and S. W. Watts, Arterial expression of 5-HT 2B and 5-HT 1B receptors during development of DOCA-salt hypertension, BMC Pharmacol, vol.3, issue.12, 2003.

C. I. Berul, M. E. Christe, and M. J. Aronovitz, Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities, Journal of Interventional Cardiac Electrophysiology, vol.2, issue.1, pp.7-14, 1998.
DOI : 10.1023/A:1009700404218

G. B. Bhat and E. R. Block, Hypoxia Directly Increases Serotonin Transport by Porcine Pulmonary Artery Endothelial Cell Plasma Membrane Vesicles, American Journal of Respiratory Cell and Molecular Biology, vol.3, issue.4, pp.363-367, 1990.
DOI : 10.1165/ajrcmb/3.4.363

P. Bianchi, O. Kunduzova, E. Masini, C. Cambon, D. Bani et al., Oxidative Stress by Monoamine Oxidase Mediates Receptor-Independent Cardiomyocyte Apoptosis by Serotonin and Postischemic Myocardial Injury, Circulation, vol.112, issue.21, pp.3297-3305, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.528133

S. Brune, T. Schmidt, U. Tebbe, and H. Kreuzer, Influence of long-term treatment with ketanserin on blood pressure, pulmonary artery pressure, and cardiac output in patients with heart failure, Cardiovascular Drugs and Therapy, vol.5, issue.6, pp.85-87, 1990.
DOI : 10.1007/BF00053434

J. Callebert, J. M. Esteve, P. Hervé, K. Peoc-'h, C. Tournois et al., Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2B Receptors in Mice, Journal of Pharmacology and Experimental Therapeutics, vol.317, issue.2, pp.724-731, 2006.
DOI : 10.1124/jpet.105.098269
URL : https://hal.archives-ouvertes.fr/hal-01274937

A. M. Carneiro, E. H. Cook, D. L. Murphy, and R. D. Blakely, Interactions between integrin ??IIb??3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans, Journal of Clinical Investigation, vol.118, issue.4, pp.1544-1552, 2008.
DOI : 10.1172/JCI33374

D. S. Choi, S. J. Ward, N. Messaddeq, J. M. Launay, and L. Maroteaux, 5-HT 2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells, Development, vol.124, pp.1745-1755, 1997.

E. H. Cook, . Jr, K. E. Fletcher, M. Wainwright, N. Marks et al., Primary Structure of the Human Platelet Serotonin 5-HT2A Receptor: Identity with Frontal Cortex Serotonin 5-HT2A Receptor, Journal of Neurochemistry, vol.63, issue.2, pp.465-469, 1994.
DOI : 10.1046/j.1471-4159.1994.63020465.x

F. Cote, C. Fligny, E. Bayard, J. M. Launay, M. D. Gershon et al., Maternal serotonin is crucial for murine embryonic development, Proceedings of the National Academy of Sciences, vol.104, issue.1, pp.329-334, 2007.
DOI : 10.1073/pnas.0606722104
URL : https://hal.archives-ouvertes.fr/hal-00166156

F. Côté, E. Thevenot, C. Fligny, Y. Fromes, M. Darmon et al., Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function, Proceedings of the National Academy of Sciences, vol.100, issue.23, 2003.
DOI : 10.1073/pnas.2233056100

Y. Dai, N. L. Dudek, T. B. Patel, and N. A. Muma, Transglutaminase-Catalyzed Transamidation: A Novel Mechanism for Rac1 Activation by 5-Hydroxytryptamine2A Receptor Stimulation, Journal of Pharmacology and Experimental Therapeutics, vol.326, issue.1, pp.153-162, 2008.
DOI : 10.1124/jpet.107.135046

G. L. Dale, P. Friese, P. Batar, S. F. Hamilton, G. L. Reed et al., Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface, Nature, vol.415, issue.6868, pp.175-179, 2002.
DOI : 10.1038/415175a

C. Davidson and J. A. Stamford, Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT1B and 5-HT1D autoreceptors, Neuropharmacology, vol.35, issue.11, pp.1627-1634, 1996.
DOI : 10.1016/S0028-3908(96)00081-0

S. Eddahibi, V. Fabre, C. Boni, M. P. Martres, B. Raffestin et al., Induction of Serotonin Transporter by Hypoxia in Pulmonary Vascular Smooth Muscle Cells : Relationship With the Mitogenic Action of Serotonin, Circulation Research, vol.84, issue.3, pp.329-336, 1999.
DOI : 10.1161/01.RES.84.3.329

S. Eddahibi, N. Hanoun, L. Lanfumey, K. P. Lesch, B. Raffestin et al., Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene, Journal of Clinical Investigation, vol.105, issue.11, pp.1555-1562, 2000.
DOI : 10.1172/JCI8678

J. M. Esteve, J. M. Launay, O. Kellermann, and L. Maroteaux, Functions of serotonin in hypoxic pulmonary vascular remodeling, Cell Biochemistry and Biophysics, vol.173, issue.Suppl, pp.33-44, 2007.
DOI : 10.1385/CBB:47:1:33
URL : https://hal.archives-ouvertes.fr/hal-01274919

B. L. Fanburg and S. L. Lee, A role for the serotonin transporter in hypoxia-induced pulmonary hypertension, Journal of Clinical Investigation, vol.105, issue.11, pp.1521-1523, 2000.
DOI : 10.1172/JCI10230

H. W. Farber and J. Loscalzo, Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.16, pp.1655-1665, 2004.
DOI : 10.1056/NEJMra035488

C. Fligny, Y. Fromes, P. Bonnin, M. Darmon, E. Bayard et al., Maternal serotonin influences cardiac function in adult offspring, The FASEB Journal, vol.22, issue.7, pp.2340-2349, 2008.
DOI : 10.1096/fj.07-100743

X. W. Fu, C. A. Nurse, V. Wong, and E. Cutz, Hypoxia-induced secretion of serotonin from intact pulmonary neuroepithelial bodies in neonatal rabbit, The Journal of Physiology, vol.365, issue.2, pp.503-510, 2002.
DOI : 10.1113/jphysiol.2001.013071

C. Guilluy, M. Rolli-derkinderen, P. L. Tharaux, G. Melino, P. Pacaud et al., Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells, Journal of Biological Chemistry, vol.282, issue.5, 2007.
DOI : 10.1074/jbc.M604195200

C. Guilluy, S. Eddahibi, C. Agard, C. Guignabert, M. Izikki et al., RhoA and Rho Kinase Activation in Human Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.12, 2009.
DOI : 10.1164/rccm.200805-691OC

P. Herve, L. Drouet, C. Dosquet, J. M. Launay, B. Rain et al., Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: Role of serotonin, The American Journal of Medicine, vol.89, issue.1, pp.117-120, 1990.
DOI : 10.1016/0002-9343(90)90111-P

P. Herve, J. M. Launay, M. L. Scrobohaci, F. Brenot, G. Simonneau et al., Increased plasma serotonin in primary pulmonary hypertension, The American Journal of Medicine, vol.99, issue.3, pp.249-254, 1995.
DOI : 10.1016/S0002-9343(99)80156-9

J. Homberg, J. Mudde, B. Braam, B. Ellenbroek, E. Cuppen et al., Blood Pressure in Mutant Rats Lacking the 5-Hydroxytryptamine Transporter, Hypertension, vol.48, issue.6, pp.115-116, 2006.
DOI : 10.1161/01.HYP.0000246306.61289.d8

J. R. Homberg, T. Pattij, M. C. Janssen, E. Ronken, S. F. De-boer et al., Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility, European Journal of Neuroscience, vol.7, issue.Suppl. 15, 2007.
DOI : 10.1111/j.1460-9568.2007.05839.x

F. Jaffre, J. Callebert, A. Sarre, N. Etienne, C. G. Nebigil et al., Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1??, and Tumor Necrosis Factor-?? Cytokine Production by Ventricular Fibroblasts, Circulation, vol.110, issue.8, pp.969-974, 2004.
DOI : 10.1161/01.CIR.0000139856.20505.57
URL : https://hal.archives-ouvertes.fr/hal-01274954

F. Jaffre, P. Bonnin, J. Callebert, H. Debbabi, V. Setola et al., Serotonin and Angiotensin Receptors in Cardiac Fibroblasts Coregulate Adrenergic-Dependent Cardiac Hypertrophy, Circulation Research, vol.104, issue.1, pp.113-123, 2009.
DOI : 10.1161/CIRCRESAHA.108.180976
URL : https://hal.archives-ouvertes.fr/inserm-00484528

T. K. Jeffery and J. C. Wanstall, Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension, Pharmacology & Therapeutics, vol.92, issue.1, pp.1-20, 2001.
DOI : 10.1016/S0163-7258(01)00157-7

C. Jonnakuty and C. Gragnoli, What do we know about serotonin?, Journal of Cellular Physiology, vol.45, issue.2, pp.301-306, 2008.
DOI : 10.1002/jcp.21533

L. Monassier, Contribution of gene-modified mice and rats to our understanding of the cardiovascular pharmacology of serotonin, Pharmacology & Therapeutics, vol.128, issue.3, pp.559-567, 2010.
DOI : 10.1016/j.pharmthera.2010.08.004
URL : https://hal.archives-ouvertes.fr/inserm-00549197

R. Kamel, S. Garcia, F. Lezoualc-'h, R. Fischmeister, S. Muller et al., Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development, BMC Developmental Biology, vol.7, issue.1, p.34, 2007.
DOI : 10.1186/1471-213X-7-34
URL : https://hal.archives-ouvertes.fr/hal-00165346

A. Keegan, I. Morecroft, D. Smillie, M. N. Hicks, and M. R. Maclean, Contribution of the 5-HT( 1B ) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT( 1B )-receptor knockout mice and the 5-HT( 1B /1D)-receptor antagonist GR127935, Circ Res, vol.89, 2001.

I. M. Keith, J. A. Will, R. J. Huxtable, and K. Weir, Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertension, Histol Histopathol, vol.2, pp.203-206, 1987.

D. Kentera, D. Susic, V. Veljkovic, G. Tucakovic, and V. Koko, Pulmonary Artery Pressure in Rats with Hereditary Platelet Function Defect, Respiration, vol.54, issue.2, pp.110-114, 1988.
DOI : 10.1159/000195509

A. Kereveur, J. Callebert, M. Humbert, P. Herve, G. Simonneau et al., High Plasma Serotonin Levels in Primary Pulmonary Hypertension : Effect of Long-Term Epoprostenol (Prostacyclin) Therapy, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.10, pp.2233-2239, 2000.
DOI : 10.1161/01.ATV.20.10.2233

G. C. Kirby and D. S. Mcqueen, Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytiyptamine, British Journal of Pharmacology, vol.29, issue.1, pp.259-269, 1984.
DOI : 10.1111/j.1476-5381.1984.tb10142.x

O. Lairez, D. Calise, P. Bianchi, C. Ordener, O. Spreux-varoquaux et al., Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload, Journal of Molecular and Cellular Cardiology, vol.46, issue.4, pp.587-595, 2009.
DOI : 10.1016/j.yjmcc.2008.12.017
URL : https://hal.archives-ouvertes.fr/inserm-00409926

J. M. Lauder, M. B. Wilkie, C. Wu, and S. Singh, Expression of 5-HT2A, 5-HT2B and 5-HT2C receptors in the mouse embryo, International Journal of Developmental Neuroscience, vol.18, issue.7, pp.653-662, 2000.
DOI : 10.1016/S0736-5748(00)00032-0

J. M. Launay, S. Loric, V. Mutel, and O. Kellermann, The 5-HT2B Receptor Controls the Overall 5-HT Transport System in the 1C11 Serotonergic Cell Line, Annals of the New York Academy of Sciences, vol.118, issue.1 ADVANCES IN S, p.247, 1998.
DOI : 10.1111/j.1749-6632.1998.tb10204.x

J. M. Launay, P. Herve, K. Peoc-'h, C. Tournois, J. Callebert et al., Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension, Nature Medicine, vol.13, issue.10, pp.1129-1135, 2002.
DOI : 10.1038/76282

S. L. Lee, W. W. Wang, B. J. Moore, and B. L. Fanburg, Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture, Circulation Research, vol.68, issue.5, 1991.
DOI : 10.1161/01.RES.68.5.1362

N. Li, N. H. Wallen, M. Ladjevardi, and P. Hjemdahl, Effects of serotonin on platelet activation in whole blood, Blood Coagulation & Fibrinolysis, vol.8, issue.8, pp.517-523, 1997.
DOI : 10.1097/00001721-199711000-00006

A. E. Linder, W. Ni, T. Szasz, R. Burnett, J. Diaz et al., A Serotonergic System in Veins: Serotonin Transporter-Independent Uptake, Journal of Pharmacology and Experimental Therapeutics, vol.325, issue.3, pp.714-722, 2008.
DOI : 10.1124/jpet.107.135699

M. R. Maclean, G. A. Deuchar, M. N. Hicks, I. Morecroft, S. Shen et al., Overexpression of the 5-Hydroxytryptamine Transporter Gene: Effect on Pulmonary Hemodynamics and Hypoxia-Induced Pulmonary Hypertension, Circulation, vol.109, issue.17, pp.2150-2155, 2004.
DOI : 10.1161/01.CIR.0000127375.56172.92

E. Marcos, S. Adnot, M. H. Pham, A. Nosjean, B. Raffestin et al., Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.4, pp.487-493, 2003.
DOI : 10.1164/rccm.200210-1212OC

R. B. Matondo, C. Punt, J. Homberg, M. J. Toussaint, R. Kisjes et al., Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration, AJP: Gastrointestinal and Liver Physiology, vol.296, issue.4, pp.963-968, 2009.
DOI : 10.1152/ajpgi.90709.2008

T. P. Mcdonald, M. Cottrell, and R. Clift, Effects of short-term hypoxia on platelet counts of mice, Blood, vol.51, pp.165-175, 1978.

T. P. Mcdonald, M. B. Cottrell, S. A. Steward, R. E. Clift, C. J. Swearingen et al., Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia, Exp Hematol, vol.20, pp.51-56, 1992.

A. Mekontso-dessap, F. Brouri, O. Pascal, P. Lechat, N. Hanoun et al., Deficiency of the 5-Hydroxytryptamine Transporter Gene Leads to Cardiac Fibrosis and Valvulopathy in Mice, Circulation, vol.113, issue.1, pp.81-89, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.554667

L. Monassier, M. A. Laplante, F. Jaffre, P. Bousquet, L. Maroteaux et al., Serotonin 5-HT2B Receptor Blockade Prevents Reactive Oxygen Species-Induced Cardiac Hypertrophy in Mice, Hypertension, vol.52, issue.2, pp.301-307, 2008.
DOI : 10.1161/HYPERTENSIONAHA.107.105551
URL : https://hal.archives-ouvertes.fr/inserm-00484531

I. Morecroft, L. Loughlin, M. Nilsen, J. Colston, Y. Dempsie et al., Functional Interactions between 5-Hydroxytryptamine Receptors and the Serotonin Transporter in Pulmonary Arteries, Journal of Pharmacology and Experimental Therapeutics, vol.313, issue.2, pp.539-548, 2005.
DOI : 10.1124/jpet.104.081182

I. Morecroft, Y. Dempsie, M. Bader, D. J. Walther, K. Kotnik et al., Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary Hypertension, Hypertension, vol.49, issue.1, pp.232-236, 2007.
DOI : 10.1161/01.HYP.0000252210.58849.78

C. G. Nebigil, P. Hickel, N. Messaddeq, J. L. Vonesch, M. P. Douchet et al., Ablation of Serotonin 5-HT2B Receptors in Mice Leads to Abnormal Cardiac Structure and Function, Circulation, vol.103, issue.24, pp.2973-2979, 2001.
DOI : 10.1161/01.CIR.103.24.2973

C. G. Nebigil, F. Jaffre, N. Messaddeq, P. Hickel, L. Monassier et al., Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy, Circulation, vol.107, issue.25, pp.3223-3229, 2003.
DOI : 10.1161/01.CIR.0000074224.57016.01

W. Ni, C. S. Wilhelm, M. Bader, D. L. Murphy, K. Lookingland et al., (+)-Norfenfluramine-Induced Arterial Contraction Is Not Dependent on Endogenous 5-Hydroxytryptamine or 5-Hydroxytryptamine Transporter, Journal of Pharmacology and Experimental Therapeutics, vol.314, issue.3, pp.953-960, 2005.
DOI : 10.1124/jpet.105.087080

W. Ni, T. J. Geddes, J. R. Priestley, T. Szasz, D. M. Kuhn et al., The existence of a local 5-hydroxytryptaminergic system in peripheral arteries, British Journal of Pharmacology, vol.276, issue.Part 2, pp.663-674, 2008.
DOI : 10.1038/bjp.2008.111

N. Paulmann, M. Grohmann, J. Voigt, B. Bert, J. Vowinckel et al., Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation, PLoS Biol, vol.7, 2009.

L. M. Pavone, P. Mithbaokar, V. Mastellone, L. Avallone, P. Gaspar et al., Fate map of serotonin transporter-expressing cells in developing mouse heart, genesis, vol.143, issue.11, pp.689-695, 2007.
DOI : 10.1002/dvg.20343

L. M. Pavone, A. Spina, R. Lo-muto, D. Santoro, V. Mastellone et al., Heart valve cardiomyocytes of mouse embryos express the serotonin transporter SERT, Biochemical and Biophysical Research Communications, vol.377, issue.2, pp.419-422, 2008.
DOI : 10.1016/j.bbrc.2008.09.152

B. R. Pitt, W. Weng, A. R. Steve, R. D. Blakely, I. Reynolds et al., Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture, Am J Physiol, vol.266, pp.178-186, 1994.

E. Qvigstad, T. Brattelid, I. Sjaastad, K. W. Andressen, K. A. Krobert et al., Appearance of a ventricular 5-HT receptor-mediated inotropic response to serotonin in heart failure, Cardiovascular Research, vol.65, issue.4, pp.869-878, 2005.
DOI : 10.1016/j.cardiores.2004.11.017

M. Rabinovitch, Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension, J Clin Invest, vol.108, 2001.

M. M. Rapport, A. A. Green, and I. H. Page, Crystalline Serotonin, Science, vol.108, issue.2804, pp.329-330, 1948.
DOI : 10.1126/science.108.2804.329

M. M. Rapport, A. A. Green, and I. H. Page, Serum vasoconstrictor, serotonin; isolation and characterization, J Biol Chem, vol.176, 1948.

J. T. Reeves, B. M. Groves, and D. Turkevich, The case for treatment of selected patients with primary pulmonary hypertension, Am Rev Respir Dis, vol.134, pp.342-346, 1986.

P. A. Robiolio, V. H. Rigolin, J. S. Wilson, J. K. Harrison, L. L. Sanders et al., Carcinoid Heart Disease : Correlation of High Serotonin Levels With Valvular Abnormalities Detected by Cardiac Catheterization and Echocardiography, Circulation, vol.92, issue.4, pp.790-795, 1995.
DOI : 10.1161/01.CIR.92.4.790

C. Rostagno, D. Prisco, M. Boddi, and L. Poggesi, Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease, Eur Respir J, vol.4, pp.147-151, 1991.

C. Roux, M. Madani, J. Launay, F. Rey, D. Citadelle et al., Serotonin deficiency in phenylketonuria embryopathy, Toxicology in Vitro, vol.9, issue.5, pp.653-662, 1995.
DOI : 10.1016/0887-2333(95)00071-F

C. Sanchez and J. Hyttel, Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding, Cellular and Molecular Neurobiology, vol.19, issue.4, pp.467-489, 1999.
DOI : 10.1023/A:1006986824213

K. Sato, S. Webb, A. Tucker, M. Rabinovitch, R. F. O-'brien et al., Factors Influencing the Idiopathic Development of Pulmonary Hypertension in the Fawn Hooded Rat, American Review of Respiratory Disease, vol.145, issue.4_pt_1, pp.793-797, 1992.
DOI : 10.1164/ajrccm/145.4_Pt_1.793

V. Setola and B. L. Roth, Why Mice Are Neither Miniature Humans nor Small Rats: A Cautionary Tale Involving 5-Hydroxytryptamine-6 Serotonin Receptor Species Variants, Molecular Pharmacology, vol.64, issue.6, 2003.
DOI : 10.1124/mol.64.6.1277

P. Steele, J. H. Ellis, . Jr, H. S. Weily, and E. Genton, Platelet survival time in patients with hypoxemia and pulmonary hypertension, Circulation, vol.55, issue.4, pp.660-661, 1977.
DOI : 10.1161/01.CIR.55.4.660

T. Tolmachova, M. Abrink, C. E. Futter, K. S. Authi, and M. C. Seabra, Rab27b regulates number and secretion of platelet dense granules, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.5872-5877, 2007.
DOI : 10.1073/pnas.0609879104

C. Tournois, V. Mutel, P. Manivet, J. M. Launay, and O. Kellermann, Cross-talk between 5-Hydroxytryptamine Receptors in a Serotonergic Cell Line: INVOLVEMENT OF ARACHIDONIC ACID METABOLISM, Journal of Biological Chemistry, vol.273, issue.28, 1998.
DOI : 10.1074/jbc.273.28.17498

D. N. Tu, A. R. Zou, Y. H. Liao, Y. M. Du, X. P. Wang et al., Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin, Sheng Li Xue Bao, vol.60, pp.525-534, 2008.

J. R. Vane, A SENSITIVE METHOD FOR THE ASSAY OF 5-HYDROXYTRYPTAMINE, British Journal of Pharmacology and Chemotherapy, vol.11, issue.3, pp.344-349, 1957.
DOI : 10.1111/j.1476-5381.1957.tb00146.x

M. Vially and V. Erspamer, Cellule enterocromaffini e cellule basigranulose acidofile nei Vertebrati, Zeitschrift f??r Zellforschung und Mikroskopische Anatomie, vol.1, issue.4, pp.743-773, 1933.
DOI : 10.1007/BF02450276

G. P. Vyssoulis, E. A. Karpanou, C. E. Pitsavos, A. A. Paleologos, T. K. Kourtis et al., Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives, Cardiovascular Drugs and Therapy, vol.8, issue.Suppl 11, pp.81-84, 1990.
DOI : 10.1007/BF00053433

D. J. Walther, J. U. Peter, S. Winter, M. Holtje, N. Paulmann et al., Serotonylation of Small GTPases Is a Signal Transduction Pathway that Triggers Platelet ??-Granule Release, Cell, vol.115, issue.7, pp.851-862, 2003.
DOI : 10.1016/S0092-8674(03)01014-6

J. C. Wanstall, S. A. Fiore, A. Gambino, and R. Chess-williams, Potentiation of 5-hydroxytryptamine (5-HT) responses by a 5-HT uptake inhibitor in pulmonary and systemic vessels: effects of exposing rats to hypoxia, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.368, issue.6, pp.520-527, 2003.
DOI : 10.1007/s00210-003-0823-3

S. W. Watts, The love of a lifetime: 5-HT in the cardiovascular system, AJP: Regulatory, Integrative and Comparative Physiology, vol.296, issue.2, pp.252-256, 2009.
DOI : 10.1152/ajpregu.90676.2008

S. W. Watts, J. R. Priestley, and J. M. Thompson, Serotonylation of Vascular Proteins Important to Contraction, PLoS ONE, vol.31, issue.5, p.5682, 2009.
DOI : 10.1371/journal.pone.0005682.g007

O. Weiss, Ueber die Wirkungen von Blutserum-Injectionen ins Blut, Archiv für die Gesamte Physiologie des Menschen und der Thiere LXV, pp.215-230, 1896.
DOI : 10.1007/BF01661741

D. S. Woulfe, J. K. Lilliendahl, S. August, L. Rauova, M. A. Kowalska et al., Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice, Blood, vol.111, issue.7, pp.3458-3467, 2008.
DOI : 10.1182/blood-2007-07-104703